• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

STAT6 是输出蛋白 1 的货物:原发性纵隔 B 细胞淋巴瘤中的生物学相关性。

STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma.

机构信息

Normandie Univ, INSERM UMR1245, UNICAEN, Caen, France.

Université Paris-Descartes, Paris, France.

出版信息

Cell Signal. 2018 Jun;46:76-82. doi: 10.1016/j.cellsig.2018.02.016. Epub 2018 Mar 1.

DOI:10.1016/j.cellsig.2018.02.016
PMID:29501729
Abstract

Primary mediastinal B-cell lymphoma (PMBL) is a distinct B-cell lymphoma subtype with unique clinicopathological and molecular features. PMBL cells are characterised by several genetic abnormalities that conduct to the constitutive activation of the Janus kinase 2/signal transducer and activator of transcription 6 (JAK2/STAT6) signalling pathway. Among recurrent genetic changes in PMBL, we previously reported that the XPO1 gene encoding exportin 1 that controls the nuclear export of cargo proteins and RNAs, is mutated (p.E571K) in about 25% of PMBL cases. We therefore hypothesized that STAT6 could be a cargo of XPO1 and that STAT6 cytoplasm/nucleus shuttle could be altered in a subset of PMBL cells. Using immunocytochemistry techniques as well as the proximity ligation assay, we showed that STAT6 bound XPO1 in PBML cell lines and in HEK-293 cells genetically engineered to produce STAT6. Moreover, XPO1-mediated export of STAT6 occurs in cells expressing either a wild-type or the E571K mutated XPO1 protein.

摘要

原发性纵隔 B 细胞淋巴瘤(PMBL)是一种具有独特临床病理和分子特征的 B 细胞淋巴瘤亚型。PMBL 细胞的特征是存在几种遗传异常,导致 Janus 激酶 2/信号转导和转录激活因子 6(JAK2/STAT6)信号通路的组成性激活。在 PMBL 的反复出现的遗传变化中,我们之前报道过,编码控制货物蛋白和 RNA 核输出的输出蛋白 1 的 XPO1 基因在大约 25%的 PMBL 病例中发生突变(p.E571K)。因此,我们假设 STAT6 可能是 XPO1 的货物,并且 STAT6 的细胞质/核穿梭可能在一部分 PMBL 细胞中发生改变。我们使用免疫细胞化学技术和邻近连接测定法,证明 STAT6 在 PMBL 细胞系和遗传工程表达 STAT6 的 HEK-293 细胞中与 XPO1 结合。此外,表达野生型或 E571K 突变 XPO1 蛋白的细胞中都存在 XPO1 介导的 STAT6 输出。

相似文献

1
STAT6 is a cargo of exportin 1: Biological relevance in primary mediastinal B-cell lymphoma.STAT6 是输出蛋白 1 的货物:原发性纵隔 B 细胞淋巴瘤中的生物学相关性。
Cell Signal. 2018 Jun;46:76-82. doi: 10.1016/j.cellsig.2018.02.016. Epub 2018 Mar 1.
2
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.一种新型 HSP110 抑制剂,增强了 XPO1 靶向治疗在原发性纵隔 B 细胞淋巴瘤和经典霍奇金淋巴瘤中的作用。
J Exp Clin Cancer Res. 2024 May 22;43(1):148. doi: 10.1186/s13046-024-03068-x.
3
Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B-cell lymphoma.XPO1 基因的反复突变及其对原发性纵隔 B 细胞淋巴瘤中核输出化合物选择性抑制剂敏感性的影响。
Am J Hematol. 2016 Sep;91(9):923-30. doi: 10.1002/ajh.24451. Epub 2016 Jul 4.
4
Constitutive STAT6 activation in primary mediastinal large B-cell lymphoma.原发性纵隔大B细胞淋巴瘤中的组成型STAT6激活
Blood. 2004 Jul 15;104(2):543-9. doi: 10.1182/blood-2003-10-3545. Epub 2004 Mar 25.
5
Recurrent mutations of the STAT6 DNA binding domain in primary mediastinal B-cell lymphoma.原发性纵隔B细胞淋巴瘤中STAT6 DNA结合域的复发性突变。
Blood. 2009 Aug 6;114(6):1236-42. doi: 10.1182/blood-2009-03-209759. Epub 2009 May 7.
6
Exportin 1-mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma.Exportin 1 介导的核质转运控制经典霍奇金淋巴瘤的药物敏感性。
Mol Oncol. 2023 Dec;17(12):2546-2564. doi: 10.1002/1878-0261.13386. Epub 2023 Apr 21.
7
EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas.EBV 阳性原发性大 B 细胞淋巴瘤:免疫组织化学和 XPO1 在纵隔淋巴瘤诊断中的作用。
Appl Immunohistochem Mol Morphol. 2020 Nov/Dec;28(10):725-730. doi: 10.1097/PAI.0000000000000820.
8
Mutation Modifies Exportin 1 Localisation and Interactome in B-cell Lymphoma.突变改变B细胞淋巴瘤中输出蛋白1的定位和相互作用组。
Cancers (Basel). 2020 Sep 30;12(10):2829. doi: 10.3390/cancers12102829.
9
XPO1 in B cell hematological malignancies: from recurrent somatic mutations to targeted therapy.B细胞血液系统恶性肿瘤中的XPO1:从复发性体细胞突变到靶向治疗
J Hematol Oncol. 2017 Feb 14;10(1):47. doi: 10.1186/s13045-017-0412-4.
10
Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.核输出选择性抑制剂(SINE)XPO1拮抗剂KPT-185对核糖体生物合成和翻译通量的抑制作用
PLoS One. 2015 Sep 4;10(9):e0137210. doi: 10.1371/journal.pone.0137210. eCollection 2015.

引用本文的文献

1
A first-in-class inhibitor of HSP110 to potentiate XPO1-targeted therapy in primary mediastinal B-cell lymphoma and classical Hodgkin lymphoma.一种新型 HSP110 抑制剂,增强了 XPO1 靶向治疗在原发性纵隔 B 细胞淋巴瘤和经典霍奇金淋巴瘤中的作用。
J Exp Clin Cancer Res. 2024 May 22;43(1):148. doi: 10.1186/s13046-024-03068-x.
2
Therapeutic targeting of nuclear export and import receptors in cancer and their potential in combination chemotherapy.治疗性靶向核输出和进口受体在癌症及其在联合化疗中的潜力。
IUBMB Life. 2024 Jan;76(1):4-25. doi: 10.1002/iub.2773. Epub 2023 Aug 25.
3
Exportin 1-mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma.
Exportin 1 介导的核质转运控制经典霍奇金淋巴瘤的药物敏感性。
Mol Oncol. 2023 Dec;17(12):2546-2564. doi: 10.1002/1878-0261.13386. Epub 2023 Apr 21.
4
Nuclear Export in Non-Hodgkin Lymphoma and Implications for Targeted XPO1 Inhibitors.非霍奇金淋巴瘤的核输出及对靶向 XPO1 抑制剂的影响。
Biomolecules. 2023 Jan 5;13(1):111. doi: 10.3390/biom13010111.
5
Genetic Landscape of Relapsed and Refractory Diffuse Large B-Cell Lymphoma: A Systemic Review and Association Analysis With Next-Generation Sequencing.复发难治性弥漫性大B细胞淋巴瘤的遗传图谱:一项系统评价及与下一代测序的关联分析
Front Genet. 2021 Dec 2;12:677650. doi: 10.3389/fgene.2021.677650. eCollection 2021.
6
Mutation Modifies Exportin 1 Localisation and Interactome in B-cell Lymphoma.突变改变B细胞淋巴瘤中输出蛋白1的定位和相互作用组。
Cancers (Basel). 2020 Sep 30;12(10):2829. doi: 10.3390/cancers12102829.
7
Obinutuzumab (GA101) vs. rituximab significantly enhances cell death, antibody-dependent cytotoxicity and improves overall survival against CD20+ primary mediastinal B-cell lymphoma (PMBL) in a xenograft NOD-scid IL2Rgnull (NSG) mouse model: a potential targeted agent in the treatment of PMBL.在异种移植NOD-scid IL2Rgnull(NSG)小鼠模型中,奥滨尤妥珠单抗(GA101)与利妥昔单抗相比,可显著增强细胞死亡、抗体依赖性细胞毒性,并提高针对CD20+原发性纵隔B细胞淋巴瘤(PMBL)的总生存率:一种治疗PMBL的潜在靶向药物。
Oncotarget. 2020 Aug 11;11(32):3035-3047. doi: 10.18632/oncotarget.27691.
8
Cyclin D1 targets hexokinase 2 to control aerobic glycolysis in myeloma cells.细胞周期蛋白D1靶向己糖激酶2以控制骨髓瘤细胞中的有氧糖酵解。
Oncogenesis. 2020 Jul 24;9(7):68. doi: 10.1038/s41389-020-00253-3.
9
Targeting nuclear import and export in hematological malignancies.靶向血液系统恶性肿瘤的核输入和输出。
Leukemia. 2020 Nov;34(11):2875-2886. doi: 10.1038/s41375-020-0958-y. Epub 2020 Jul 5.
10
Epigenetic regulation of miR-518a-5p-CCR6 feedback loop promotes both proliferation and invasion in diffuse large B cell lymphoma.miR-518a-5p-CCR6 反馈环的表观遗传调控促进弥漫性大 B 细胞淋巴瘤的增殖和侵袭。
Epigenetics. 2021 Jan;16(1):28-44. doi: 10.1080/15592294.2020.1786317. Epub 2020 Jun 30.